Depression symptoms and quality of life among individuals with aspirin-exacerbated respiratory disease

Jonathan M. Feldman, Ariel E. Zeigler, Krista Nelson, Esperanza Morales-Raveendran, Teresa Pelletier, Gigia Roizen Gottlieb, Zhen Ren, Elina Jerschow

Research output: Contribution to journalArticle

Abstract

Objective: Patients with aspirin-exacerbated respiratory disease (AERD) have high disease burden due to the severity of asthma and sinonasal symptoms. There is limited research on the psychological well-being and subjective experiences of patients with AERD. This study examined levels of depression symptoms, asthma-related quality of life and asthma control among AERD patients. Methods: Thirty-two adults with AERD and 39 patients without AERD (asthma-only) were recruited from outpatient asthma/allergy clinics. The sample was largely comprised of ethnic minority, inner-city patients who ranged in age from 19 to 84 years old. Participants completed the Beck Depression Inventory (BDI), the Mini Asthma Quality of Life Questionnaire (Mini AQLQ), a self-report rating of asthma severity and spirometry testing. Asthma control and severity were determined following national guidelines. Results: AERD patients reported lower levels of depression symptoms (p = 0.049), better overall asthma-related quality of life (p < 0.001), and perceived their asthma to be less severe (p = 0.01) compared to asthma-only patients. However, clinician ratings of asthma severity were more severe for AERD than asthma-only patients (p = 0.006). No significant differences were found between the groups on asthma controller medications or oral corticosteroid bursts for asthma. Conclusions: AERD patients may be resilient given their low levels of depression symptoms and positive views of asthma-related impairment despite higher clinician-rated asthma severity. The adult onset nature of asthma in AERD might be a protective factor on mental health. Future studies should explore mechanisms linking AERD and positive psychological health outcomes and subjective perception of asthma.

Original languageEnglish (US)
JournalJournal of Asthma
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Aspirin
Asthma
Quality of Life
Depression
Psychology
Diagnostic Self Evaluation
Spirometry
Self Report

Keywords

  • Mental health
  • minority groups
  • protective factors
  • resilience
  • signs and symptoms

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Feldman, J. M., Zeigler, A. E., Nelson, K., Morales-Raveendran, E., Pelletier, T., Gottlieb, G. R., ... Jerschow, E. (Accepted/In press). Depression symptoms and quality of life among individuals with aspirin-exacerbated respiratory disease. Journal of Asthma. https://doi.org/10.1080/02770903.2018.1490754

Depression symptoms and quality of life among individuals with aspirin-exacerbated respiratory disease. / Feldman, Jonathan M.; Zeigler, Ariel E.; Nelson, Krista; Morales-Raveendran, Esperanza; Pelletier, Teresa; Gottlieb, Gigia Roizen; Ren, Zhen; Jerschow, Elina.

In: Journal of Asthma, 01.01.2018.

Research output: Contribution to journalArticle

Feldman, Jonathan M. ; Zeigler, Ariel E. ; Nelson, Krista ; Morales-Raveendran, Esperanza ; Pelletier, Teresa ; Gottlieb, Gigia Roizen ; Ren, Zhen ; Jerschow, Elina. / Depression symptoms and quality of life among individuals with aspirin-exacerbated respiratory disease. In: Journal of Asthma. 2018.
@article{35164d56b93d43e9866ff6cf468f74b2,
title = "Depression symptoms and quality of life among individuals with aspirin-exacerbated respiratory disease",
abstract = "Objective: Patients with aspirin-exacerbated respiratory disease (AERD) have high disease burden due to the severity of asthma and sinonasal symptoms. There is limited research on the psychological well-being and subjective experiences of patients with AERD. This study examined levels of depression symptoms, asthma-related quality of life and asthma control among AERD patients. Methods: Thirty-two adults with AERD and 39 patients without AERD (asthma-only) were recruited from outpatient asthma/allergy clinics. The sample was largely comprised of ethnic minority, inner-city patients who ranged in age from 19 to 84 years old. Participants completed the Beck Depression Inventory (BDI), the Mini Asthma Quality of Life Questionnaire (Mini AQLQ), a self-report rating of asthma severity and spirometry testing. Asthma control and severity were determined following national guidelines. Results: AERD patients reported lower levels of depression symptoms (p = 0.049), better overall asthma-related quality of life (p < 0.001), and perceived their asthma to be less severe (p = 0.01) compared to asthma-only patients. However, clinician ratings of asthma severity were more severe for AERD than asthma-only patients (p = 0.006). No significant differences were found between the groups on asthma controller medications or oral corticosteroid bursts for asthma. Conclusions: AERD patients may be resilient given their low levels of depression symptoms and positive views of asthma-related impairment despite higher clinician-rated asthma severity. The adult onset nature of asthma in AERD might be a protective factor on mental health. Future studies should explore mechanisms linking AERD and positive psychological health outcomes and subjective perception of asthma.",
keywords = "Mental health, minority groups, protective factors, resilience, signs and symptoms",
author = "Feldman, {Jonathan M.} and Zeigler, {Ariel E.} and Krista Nelson and Esperanza Morales-Raveendran and Teresa Pelletier and Gottlieb, {Gigia Roizen} and Zhen Ren and Elina Jerschow",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/02770903.2018.1490754",
language = "English (US)",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Depression symptoms and quality of life among individuals with aspirin-exacerbated respiratory disease

AU - Feldman, Jonathan M.

AU - Zeigler, Ariel E.

AU - Nelson, Krista

AU - Morales-Raveendran, Esperanza

AU - Pelletier, Teresa

AU - Gottlieb, Gigia Roizen

AU - Ren, Zhen

AU - Jerschow, Elina

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Patients with aspirin-exacerbated respiratory disease (AERD) have high disease burden due to the severity of asthma and sinonasal symptoms. There is limited research on the psychological well-being and subjective experiences of patients with AERD. This study examined levels of depression symptoms, asthma-related quality of life and asthma control among AERD patients. Methods: Thirty-two adults with AERD and 39 patients without AERD (asthma-only) were recruited from outpatient asthma/allergy clinics. The sample was largely comprised of ethnic minority, inner-city patients who ranged in age from 19 to 84 years old. Participants completed the Beck Depression Inventory (BDI), the Mini Asthma Quality of Life Questionnaire (Mini AQLQ), a self-report rating of asthma severity and spirometry testing. Asthma control and severity were determined following national guidelines. Results: AERD patients reported lower levels of depression symptoms (p = 0.049), better overall asthma-related quality of life (p < 0.001), and perceived their asthma to be less severe (p = 0.01) compared to asthma-only patients. However, clinician ratings of asthma severity were more severe for AERD than asthma-only patients (p = 0.006). No significant differences were found between the groups on asthma controller medications or oral corticosteroid bursts for asthma. Conclusions: AERD patients may be resilient given their low levels of depression symptoms and positive views of asthma-related impairment despite higher clinician-rated asthma severity. The adult onset nature of asthma in AERD might be a protective factor on mental health. Future studies should explore mechanisms linking AERD and positive psychological health outcomes and subjective perception of asthma.

AB - Objective: Patients with aspirin-exacerbated respiratory disease (AERD) have high disease burden due to the severity of asthma and sinonasal symptoms. There is limited research on the psychological well-being and subjective experiences of patients with AERD. This study examined levels of depression symptoms, asthma-related quality of life and asthma control among AERD patients. Methods: Thirty-two adults with AERD and 39 patients without AERD (asthma-only) were recruited from outpatient asthma/allergy clinics. The sample was largely comprised of ethnic minority, inner-city patients who ranged in age from 19 to 84 years old. Participants completed the Beck Depression Inventory (BDI), the Mini Asthma Quality of Life Questionnaire (Mini AQLQ), a self-report rating of asthma severity and spirometry testing. Asthma control and severity were determined following national guidelines. Results: AERD patients reported lower levels of depression symptoms (p = 0.049), better overall asthma-related quality of life (p < 0.001), and perceived their asthma to be less severe (p = 0.01) compared to asthma-only patients. However, clinician ratings of asthma severity were more severe for AERD than asthma-only patients (p = 0.006). No significant differences were found between the groups on asthma controller medications or oral corticosteroid bursts for asthma. Conclusions: AERD patients may be resilient given their low levels of depression symptoms and positive views of asthma-related impairment despite higher clinician-rated asthma severity. The adult onset nature of asthma in AERD might be a protective factor on mental health. Future studies should explore mechanisms linking AERD and positive psychological health outcomes and subjective perception of asthma.

KW - Mental health

KW - minority groups

KW - protective factors

KW - resilience

KW - signs and symptoms

UR - http://www.scopus.com/inward/record.url?scp=85055134765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055134765&partnerID=8YFLogxK

U2 - 10.1080/02770903.2018.1490754

DO - 10.1080/02770903.2018.1490754

M3 - Article

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

ER -